1.Clinical value of gallbladder function in predicting postoperative complications after endoscopic treatment of calculus of common bile duct
Jianchao WANG ; Huaibo ZHANG ; Ronglong MA
China Journal of Endoscopy 2024;30(10):37-43
Objective To investigate the clinical value of gallbladder function in predicting postoperative complications after endoscopic treatment of calculus of common bile duct.Methods 118 patients with complete gallbladder who underwent endoscopic clearance for calculus of common bile duct were selected from January 2018 to December 2022.After the liver function recovered to normal,the patients underwent lipid meal ultrasound examination to evaluate fasting volume,residual volume,and gallbladder ejection fraction(GBEF).The relationship between clinical features,gallbladder function and recurrent biliary complications was analyzed in patients with calculus of common bile duct.Results Among the 118 patients with calculus of common bile duct,86 had concomitant cholecystolithiasis,while 32 did not.During the follow-up period,23 patients developed biliary complications.Among the 86 patients with concomitant cholecystolithiasis,15 had spontaneous clearance of cholecystolithiasis,14 underwent cholecystectomy due to acute cholecystitis or recurrent abdominal pain,and 6 died of non-biliary causes.The GBEF of the patients with cholecystolithiasis was significantly lower.Cholecystolithiasis,alcohol consumption,and more than one endoscopic treatment were the risk factors for recurrent biliary complications after endoscopic treatment of calculus of common bile duct.Conclusion Patients with calculus of common bile duct combined with cholecystolithiasis have poor GBEF.Cholecystolithiasis,alcohol consumption,and more than one endoscopic treatment are the risk factors for recurrent biliary complications after endoscopic treatment of calculus of common bile duct.Since cholecystolithiasis may spontaneously resolve,conservative monitoring of the gallbladder after endoscopic treatment for calculus of common bile duct is appropriate,but regular follow-up is necessary for high-risk patients.
2.Optimization of extraction process of prescription medicinal materials of compound Yangshe granules
Jianchao YU ; Chao MA ; Mengmeng WANG ; Dan LI ; Rongmei LIU ; Jiyong LIU
Journal of Pharmaceutical Practice 2023;41(4):240-244
Objective Optimizing the extraction process of prescription medicinal materials of hospital preparation of compound Yangshe granules. Methods A high performance liquid chromatograph (HPLC) quantitative method was established for deacetyl asperulosidicacid methyl ester (DME) and ferulic acid (FC) of the active ingredient. Based on the content of DME, FC and the yield of extract, the extraction process of compound Yangshe granule extract was optimized using central composite design-response surface methodology. Results The established HPLC method of quantification of active components in compound Yangshe granules met the requirements of method validation. The optimal extraction process optimized by central composite design-response surface methodology were as follows: the weight of extraction solvent was 12 times of the medicinal slices, the alcohol concentration was 73% and the extraction time was 60 min. Conclusion In this study, the quantitative method of active components in compound Yangshe granule by HPLC has been successfully established, and the optimized extraction process is simple and easy to operate with good repeatability.
3.Tumoral calcinosis on thigh in a hemodialysis patient and literature review
Feng WEN ; Renwei HUANG ; Sijia LI ; Sheng LI ; Lei FU ; Lixia XU ; Ting LIN ; Zhonglin FENG ; Jianchao MA ; Ping MEI ; Wenjian WANG ; Xinling LIANG ; Shuangxin LIU
Chinese Journal of Nephrology 2023;39(6):465-468
The paper reported a patient under maintained hemodialysis for 11 years, with a large mass appeared in the right thigh after local injury. The mass was clinically considered as tumoral calcinosis combined with clinical, imaging and pathological findings. Several treatments such as enhancing dialysis adequacy, low calcium dialysate, calcimimetic agent, non-calcium- phosphorus binding agents, parathyroidectomy and intravenous infusion of sodium thiosulfate could not vanish the mass. Finally, the lump was surgically removed. The treatment of tumoral calcinosis in the hemodialysis patient can provide a instruction for similar situations in clinical practice.
4.The clinical application of the open supraclavicular approach in thyroidectomy
Linjie MA ; Shaoxin WANG ; Chao LI ; Jianchao CHEN ; Mingfang JIANG ; Zhonggui HUANG ; Jie DENG
Chinese Journal of Clinical Oncology 2019;46(7):357-360
Objective: To analyze the clinical application of the open supraclavicular approach in thyroidectomy. Methods: The clinical practicability of open supraclavicular thyroidectomy was explored by comparing the traditional anterior low arc incision thyroidectomy procedure with open supraclavicular thyroidectomy in terms of patients'aesthetic satisfaction, effectiveness of the operation, operation time, and so on. Result: Twenty-two cases of open supraclavicular thyroidectomy (group B) had better aesthetic satisfaction than 29 cases of traditional incision thyroidectomy (group A)(P<0.05), and had the same operative effect with traditional incision. Open supraclavicular thyroidectomy is associated with good aesthetic satisfaction, and has the same effect as the traditional incision does. Conclusions: Open supraclavicular thyroidectomy has good clinical value for benign thyroid tumors and some malignant tumors that require unilateral lobectomy, and even for tumors larger than the incision diameter. It has good aesthetic value while ensuring the curative effect of surgery.
6.Diagnostic value of circulating miRNAs for predicting pneumonia-associated sepsis in elderly patients
Wenping ZHANG ; Jianchao JIA ; Lijun MA ; Zi LIU ; Dan SI ; Kai WANG ; Xingang HU ; Jing ZHANG ; Zhida LIU ; Min ZHU ; Cuijie TIAN ; Taibo HUANG ; Hongmei LIU ; Jianjian CHENG
Chinese Journal of Geriatrics 2018;37(7):783-787
Objective To evaluate the predicting value of circulating miRNAs for sepsis secondary to pneumonia in elderly patients.Methods From April 2016 to January 2017,44 cases with sepsis secondary to pneumonia,52 elderly patients with pneumonia and 21 healthy older adults as control were involved in this study.The expression levels of MiRNA-150 5p,miRNA-25-3p,miRNA-122 5p and miRNA-223-3p in plasma were evaluated by fluorescence quantitative PCR.The demographic characteristics,sequential organ failure assessment (SOFA)scores,prognosis and days stayed in ICU were recorded.The area under the receiver operating charaeteristic(ROC)curve was used to calculated the specificity and sensitivity of miRNA in identifying sepsis-associated pneumonia.Results There were significantly differences among levels of circulating miRNA-223-3p in pneumonia,sepsis and healthy control groups(F =36.441,P =0.000),△CT values were 2.39 ± 1.36,1.44± 1.43,and 4.58 ± 0.91,respectively.The relative expression levels of miRNA-223-3p in the three groups were significantly different (P =0.000),which were 0.189 (0.107,0.367),0.361 (0.221,0.735),and 0.044 (0.022,0.061),respectively.The AUC of miRNA-223-3p for predicting sepsis from pneumonia was 0.964(95 %CI =0.925 1.000).At a cutoff value of 2.759,miRNA-223-3p yielded a sensitivity of 82.9% and a specificity of 100.0%.Conclusions MiRNA-223-3p expression is up-regulated in patients with sepsis secondary to pneumonia compared to that of patients with pneumonia,and it could be used to predict sepsis associated pneumonia.
7.Construction and Application of Data Analysis Platform of the Hospital Based on Data Warehouse
Shaofeng MA ; Mingfeng WEN ; Jianchao CHEN
Journal of Medical Informatics 2017;38(7):18-21,50
The paper analyzes the deficiencies of the traditional Hospital Information System (HIS),establishes the hospital data mining and analysis platform,introduces the platform architecture,builds the data mining models themed by analysis of hospital leaders,supervision and management of antibacterial drugs,analysis of hospital quality,analysis of single disease,expenditure control by medical insurance,etc.,and puts forward the smart solutions to improve the service tevel of hospitals on the basis of above.
8.Renal expression of RANK-RANKL in a rat model of puromycin aminonucleoside nephropathy.
Zhonglin FENG ; Shuangxin LIU ; Wei SHI ; Houqin XIAO ; Xinling LIANG ; Xiaoying LIU ; Zhiming YE ; Suxia WANG ; Yongzheng LIANG ; Bin ZHANG ; Wenjian WANG ; Yanhui LIU ; Ping MEI ; Lixia XU ; Jianchao MA ; Yunfeng XIA
Journal of Southern Medical University 2014;34(1):65-69
OBJECTIVETo investigate RANK-RANKL expression in the kidneys of a rat model of puromycin aminonucleoside nephropathy (PAN).
METHODSThirty-six SD rats were randomly divided into PAN model group and normal control group. PAN was induced by a single intravenous injection of 100 mg/kg puromycin aminonucleoside. Serum creatinine and 24-hour urinary protein were measured on days 3, 7, and 14 after the injection, and renal pathologies were assessed with optical and immune transmission electron microscopy. The expression of RANK and RANKL in the kidneys was examined using reverse transcription-polymerase chain reaction (RT-PCR) and Western blotting.
RESULTSThe PAN model rats showed massive proteinuria and elevated serum creatinine on day 3, which peaked on day 7. RANK-RANKL protein and mRNA expressions in PAN model group was higher than those in the control group. In the PAN rats, RANK was expressed mainly on the top cell membrane and in the cytoplasm of renal podocytes with a significantly increased expression level compared with that in the control group.
CONCLUSIONThe PAN rat model shows aberrant RANK and RANKL expressions in the podocytes, indicating their contribution to podocyte injury in PAN.
Animals ; Creatinine ; blood ; Female ; Kidney ; drug effects ; metabolism ; Kidney Diseases ; chemically induced ; metabolism ; pathology ; Male ; Podocytes ; drug effects ; metabolism ; Proteinuria ; pathology ; Puromycin Aminonucleoside ; adverse effects ; RANK Ligand ; metabolism ; Rats ; Rats, Sprague-Dawley ; Receptor Activator of Nuclear Factor-kappa B ; metabolism
9.Renal expression of RANK- RANKL in a rat model of puromycin aminonucleoside nephropathy
Zhonglin FENG ; Shuangxin LIU ; Wei SHI ; Houqin XIAO ; Xinling LIANG ; Xiaoying LIU ; Zhiming YE ; Suxia WANG ; Yongzheng LIANG ; Bin ZHANG ; Wenjian WANG ; Yanhui LIU ; Ping MEI ; Lixia XU ; Jianchao MA ; Yunfeng XIA
Journal of Southern Medical University 2014;(1):65-69
Objective To investigate RANK-RANKL expression in the kidneys of a rat model of puromycin aminonucleoside nephropathy (PAN). Methods Thirty-six SD rats were randomly divided into PAN model group and normal control group. PAN was induced by a single intravenous injection of 100 mg/kg puromycin aminonucleoside. Serum creatinine and 24-hour urinary protein were measured on days 3, 7, and 14 after the injection, and renal pathologies were assessed with optical and immune transmission electron microscopy. The expression of RANK and RANKL in the kidneys was examined using reverse transcription-ploymerase chain reaction (RT-PCR) and Western blotting. Results The PAN model rats showed massive proteinuria and elevated serum creatinine on day 3, which peaked on day 7. RANK-RANKL protein and mRNA expressions in PAN model group was higher than those in the control group. In the PAN rats, RANK was expressed mainly on the top cell membrane and in the cytoplasm of renal podocytes with a significantly increased expression level compared with that in the control group. Conclusion The PAN rat model shows aberrant RANK and RANKL expressions in the podocytes, indicating their contribution to podocyte injury in PAN.
10.Renal expression of RANK- RANKL in a rat model of puromycin aminonucleoside nephropathy
Zhonglin FENG ; Shuangxin LIU ; Wei SHI ; Houqin XIAO ; Xinling LIANG ; Xiaoying LIU ; Zhiming YE ; Suxia WANG ; Yongzheng LIANG ; Bin ZHANG ; Wenjian WANG ; Yanhui LIU ; Ping MEI ; Lixia XU ; Jianchao MA ; Yunfeng XIA
Journal of Southern Medical University 2014;(1):65-69
Objective To investigate RANK-RANKL expression in the kidneys of a rat model of puromycin aminonucleoside nephropathy (PAN). Methods Thirty-six SD rats were randomly divided into PAN model group and normal control group. PAN was induced by a single intravenous injection of 100 mg/kg puromycin aminonucleoside. Serum creatinine and 24-hour urinary protein were measured on days 3, 7, and 14 after the injection, and renal pathologies were assessed with optical and immune transmission electron microscopy. The expression of RANK and RANKL in the kidneys was examined using reverse transcription-ploymerase chain reaction (RT-PCR) and Western blotting. Results The PAN model rats showed massive proteinuria and elevated serum creatinine on day 3, which peaked on day 7. RANK-RANKL protein and mRNA expressions in PAN model group was higher than those in the control group. In the PAN rats, RANK was expressed mainly on the top cell membrane and in the cytoplasm of renal podocytes with a significantly increased expression level compared with that in the control group. Conclusion The PAN rat model shows aberrant RANK and RANKL expressions in the podocytes, indicating their contribution to podocyte injury in PAN.

Result Analysis
Print
Save
E-mail